跳到正文
EMA What's New·· 1 小时前AI 评分15

EMA 完成高氯酸盐 PSUSA 定期安全性更新报告单次评估,结论为维持现状

PSUSA/00002486/202603

AI 导读

EMA 对欧盟已上市药品中所含活性物质高氯酸盐完成 PSUSA 单次评估,程序编号 PSUSA/00002486/202603,监管结论为维持(Maintenance)。PSUSA 是对欧盟已授权药品相关定期安全性更新报告(PSUR)的单次评估,PSUR 由上市许可持有人在授权后规定时间点定期提交。

正文 · 原文

About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

Active substance(s) in scope of the PSUSA procedure

perchlorates

Procedure number

PSUSA/00002486/202603

Regulatory outcome

Maintenance

来源:EMA What's New · ema.europa.eu

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。